Oramed Pharmaceuticals
ORMP
#9215
Rank
S$0.21 B
Marketcap
S$5.33
Share price
1.96%
Change (1 day)
73.55%
Change (1 year)

Oramed Pharmaceuticals (ORMP) Fails to deliver data

Key failure to deliver metrics for Oramed Pharmaceuticals:

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Oramed Pharmaceuticals (ORMP) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Oramed Pharmaceuticals (ORMP) - since 2013

Volume in USD (price x number of shares), data since 2013

Oramed Pharmaceuticals (ORMP) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2026S$0.77 M-18.37%
2025S$0.94 M145.3%
2024S$0.38 M-92.62%
2023S$5.23 M-82.2%
2022S$29.42 M15.91%
2021S$25.38 M418.21%
2020S$4.89 M429.07%
2019S$0.92 M29.09%
2018S$0.71 M-73.46%
2017S$2.7 M-85.35%
2016S$18.44 M118.71%
2015S$8.43 M-34.36%
2014S$12.85 M166.85%
2013S$4.81 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
Novo Nordisk
NVO
S$59.54 MS$0.46 B๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark
Sanofi
SNY
S$19.72 MS$38.78 M๐Ÿ‡ซ๐Ÿ‡ท France
Ultragenyx Pharmaceutical
RARE
S$4.45 MS$14.72 M๐Ÿ‡บ๐Ÿ‡ธ USA
Lexicon Pharmaceuticals
LXRX
S$1.06 MS$3.5 M๐Ÿ‡บ๐Ÿ‡ธ USA
Compugen
CGEN
S$0.21 MS$1.48 M๐Ÿ‡ฎ๐Ÿ‡ฑ Israel